Patents by Inventor Nuclea Biotechnologies, Inc.

Nuclea Biotechnologies, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USP2A PEPTIDES AND ANTIBODIES
    Publication number: 20130109587
    Abstract: The invention relates to novel USP2a peptides and antibodies, as well as nucleic acids related to them. The peptides, antibodies and the nucleic acids are useful for the detection, staging and monitoring of the progression of cancer, as well as for determining or monitoring the efficacy of treatment.
    Type: Application
    Filed: October 24, 2012
    Publication date: May 2, 2013
    Applicant: NUCLEA BIOTECHNOLOGIES, INC.
    Inventor: Nuclea Biotechnologies, Inc.
  • PREDICTIVE BIOMARKERS FOR BREAST CANCER
    Publication number: 20130095483
    Abstract: The invention relates to compositions and methods for detecting, screening, diagnosing or determining the progression of, regression of and/or survival from a proliferative disease or condition, specifically breast cancer. The invention also provides new assays and kits for the staging or stratifying breast cancer patients or patients suspected of having breast cancer.
    Type: Application
    Filed: October 15, 2012
    Publication date: April 18, 2013
    Applicant: NUCLEA BIOTECHNOLOGIES, INC.
    Inventor: Nuclea Biotechnologies, Inc.